The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane - Riesco-Eizaguirre, G; Gutierrez-Martinez, P; Garcia-Cabezas, M A; Nistal, M; Santisteban, P (Endocr Relat Cancer, 2006)